Committed to excellence in governance.
The ARIAD Board of Directors is a team of experienced, respected business leaders, committed to the highest standards of corporate governance, sound business practices and financial transparency.
Board of directors
Harvey J. Berger, M.D.
Chairman and Chief Executive Officer, ARIAD Pharmaceuticals, Inc.
Jay R. LaMarche
Former Executive Vice President, Chief Financial Officer and Treasurer, ARIAD Pharmaceuticals, Inc.
Alexander J. Denner, Ph.D.
Founding Partner, Sarissa Capital Management
Athanase Lavidas, Ph.D.
Chairman and Chief Executive Officer, Lavipharm Group
Chief Executive Officer, Mersana Therapeutics
Massimo Radaelli, Ph.D.
Chairman and Chief Executive Officer of Bioakos Pharma
Norbert G. Riedel, Ph.D.
President and Chief Executive Officer, Naurex, Inc.
Sarah J. Schlesinger, M.D.
Senior Attending Physician and Associate Professor of Clinical Investigation, The Rockefeller University
Independent Business Advisor and Lead Director, ARIAD Pharmaceuticals, Inc.